Canakinumab in patients with Schnitzler's syndrome

Trial Profile

Canakinumab in patients with Schnitzler's syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Dec 2013

At a glance

  • Drugs Canakinumab (Primary)
  • Indications Schnitzler syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Dec 2013 New trial record
    • 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top